Analysis of entire transparent rodent bodies after clearing could provide holistic biological information in health and disease, but reliable imaging and quantification of fluorescent protein signals deep inside the tissues has remained a challenge. Here, we developed vDISCO, a pressure-driven, nanobody-based whole-body immunolabeling technology to enhance the signal of fluorescent proteins by up to two orders of magnitude. This allowed us to image and quantify subcellular details through bones, skin and highly autofluorescent tissues of intact transparent mice. For the first time, we visualized whole-body neuronal projections in adult mice. We assessed CNS trauma effects in the whole body and found degeneration of peripheral nerve terminals in the torso. Furthermore, vDISCO revealed short vascular connections between skull marrow and brain meninges, which were filled with immune cells upon stroke. Thus, our new approach enables unbiased comprehensive studies of the interactions between the nervous system and the rest of the body.
M ost diseases, even when arising in a specific site, eventually affect the entire organism. Histological techniques developed in the last century have been the standard procedure for charting pathology, yet a more complete understanding of biological mechanisms requires an unbiased exploration of the whole organism, not just pre-defined tissues.
However, mammalian tissues are naturally opaque, hindering high-resolution imaging in any tissue deeper than a few hundred micrometers, a major reason why sectioning is needed for histological examination of target organs 1 . Recent innovations in tissue clearing technology now allow three-dimensional (3D) histological examination of intact organs [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . Tissue clearing is a chemical process aiming to match refractive indices throughout intact tissues, thus rendering them transparent and allowing deep-tissue fluorescent microscope imaging. Most initial applications of tissue clearing relied on the assessment of endogenous fluorescent proteins expressed in the mouse CNS. More recently, deep-tissue immunolabeling methods have enhanced the quality of imaging for whole rodent organs as well as human embryos thanks to the conjugation of bright fluorescent dyes with secondary antibodies 4, 13, 14 . A few studies have even rendered entire adult mouse bodies transparent after removal of the skin 3, [15] [16] [17] [18] and allowed head-to-toe light-sheet microscopy imaging of intact adult mice 17, 18 . All wholebody clearing and imaging methods to date rely on transgenic expression of fluorescent proteins such as enhanced green fluorescent protein (EGFP), enhanced yellow fluorescent protein (EYFP) and mCherry 17, 18 . While these fluorescent proteins emit light in the visible spectrum, skeletal muscles and other bodily tissues possess obstructive autofluorescence in this range 19 . In addition, fluorescent proteins are often less bright compared with many synthetic fluorophores, and their signal intensity is further attenuated during the clearing and imaging procedure. Together, these bottlenecks hinder reliable detection and quantification of subcellular details in centimeters-thick transparent mice and therefore require reliance on imaging of dissected organs for quantifications, compromising the benefits of whole-body transparency.
Here we developed a whole-body immunolabeling method, named vDISCO (nanobody(V H H)-boosted 3D imaging of solventcleared organs), to boost the signal of fluorescent proteins using nanobodies, which consist of the variable domain of heavy chain antibodies (V H H) 20 . This technology can enhance fluorescent signals more than 100 times and thereby allows head-to-toe light sheet microscopy scanning of transparent mice (panoptic imaging) and quantification of subcellular details. We used this technology to construct the first neuronal projection map of an adult mouse and to reveal far-reaching changes in neuronal projections and inflammatory processes following acute CNS injuries. Panoptic imaging also revealed short vascular connections between the skull marrow Technical RepoRT NATure NeurOSCIeNCe and meninges (both at the brain surface and sagittal sinus), which may serve as immune gateways following stroke.
Results
vDISCO principles and signal enhancement. Quantitative assessments of intact transparent mouse bodies remained a major challenge impeding the study of neurological diseases at the whole-body scale. We reasoned that fluorescent proteins such as EGFP and red fluorescent protein (RFP) are relatively dim compared with bright fluorochromes (for example, Alexa and Atto dyes) after tissue clearing, making them difficult to detect in centimeters-thick mouse bodies, especially through intact thick bones (for example, skull and vertebrae) and skin. Therefore, we set out to enhance the signal of fluorescent proteins via whole-body immunolabeling with brighter and more stable fluorescent dyes to provide a much higher contrast (signal-to-background ratio) in cleared mice. Furthermore, using fluorescent dyes in the far-red spectrum could help to overcome tissue autofluorescence, thus allowing reliable detection of subcellular details in all tissues 4, 19 ( Supplementary Fig. 1 ). We reasoned that nanobodies are particularly suited to achieve thorough immunolabeling throughout entire adult mouse bodies because of their small molecular weight (12-15 kDa) compared with that of conventional antibodies (~150 kDa) 3, 20 . Indeed, nanobodies were more efficient for labeling large tissues compared with conventional antibodies ( Supplementary Figs. 2 and 3 ).
First, we tested the signal quality of nanobody labeling in dissected mouse brains from Thy1-GFP-M mice, in which a subset of neurons express EGFP 21 . Following the nanoboosting, the tissues were cleared using organic solvents 6, 7 . We found that nanoboosting enhanced the signal intensity by one to two orders of magnitude compared with direct imaging of fluorescent proteins ( Fig. 1a-i ). In the nanoboosted samples, fine details of neurons were evident even in the deep brain regions of Thy1-GFP-M mice (compare Fig. 1b ,c with Fig. 1e ,f). We also obtained a similar signal intensity increase in the cerebellum of Thy1-GFP-M brains (compare Fig. 1g with Fig. 1h ), which is notoriously difficult to clear due to the high lipid content.
A major aim of tissue clearing approaches is to perform automated quantifications in large imaging datasets in an unbiased and timely way. Towards this goal, we used the NeuroGPS-Tree algorithm, a robust, automated neuron-tracing tool that was recently developed for tracing neurons in scans of cortical regions obtained by high-resolution confocal microscopy 22 . We found that virtually all of the neuronal cell bodies and neurites were detected and linked to each other as complete neurons upon vDISCO nanoboosting in light-sheet microscopy scans (Supplementary Figs. 4 and 5) . In contrast, in unboosted samples or in standard immunoglobulin G antibody-boosted samples, many fine extensions of neurons were not identified or not connected to somas and neuronal trees ( Supplementary Fig. 4 ). Nanoboosting allowed imaging not only of neuronal details but also of smaller individual cells such as microglia cells and immune cells ( Fig. 1j-m and Supplementary Fig. 6 ). Compared with unboosted samples, we could resolve fine details of microglia cells in intact transparent brains of CX3CR1 GFP/+ mice using light-sheet microscopy ( Fig. 1j-m and Supplementary Video 1). Nanoboosting also enabled automated quantification of CX3CR1 GFP + cells using the ClearMap algorithms 23 : we found approximately 2.3 million microglia cells in the adult mouse brain ( Supplementary Fig. 7a ). We also automatically quantified microglia in all brain regions annotated by the Allen Brain Atlas. Thereby we found, for example, ~150,000 microglia in the hippocampus and ~50,000 in the thalamus of adult mice ( Supplementary  Fig. 7b-k ). Furthermore, we found no significant decrease in signal intensity over time of the same samples, suggesting that vDISCO nanoboosting stabilizes the fluorescent signal ( Fig. 1n,o) , allowing long-term preservation and re-imaging of the samples. Thus, owing to the enormous enhancement and stabilization of fluorescent signals using nanobodies, we could use available computational tools to automatically trace neurons and count cell numbers in images acquired by light-sheet microscopy.
vDISCO allows panoptic imaging of intact adult mouse bodies.
To apply whole-body clearing technology at the systems level, it is critical to obtain information not only from dissected organs but also from intact transparent bodies. Towards this goal, we aimed at establishing an approach to achieve nanoboosting in the entire mouse body. We reasoned that vDISCO amplification of the fluorescent signals would allow reliable quantification of cells through intact thick bones and highly autofluorescent muscles. To ensure homogeneous delivery of nanobodies into all body regions, we used high-pressure cardiac perfusion with two-to three-fold increased pressure compared with standard perfusion protocols (160-230 mmHg compared with 70-110 mmHg (ref. 24 )). We also illustrated the effect of high-pressure delivery compared with standard pressure using methylene blue. This novel high-pressure delivery approach facilitated a consistent distribution of the dye into deep tissues ( Supplementary Fig. 8 ). Assessing the tissue integrity upon high-pressure delivery, we did not observe any structural changes ( Supplementary Fig. 9 ). Furthermore, we used a permeabilization solution containing Triton X-100, methyl-β -cyclodextrin (to extract the cholesterol from membranes) and trans-1-acetyl-4-hydroxy-l-proline (to loosen the collagen network) 12 . To further reduce the background signal caused by the residual blood and to decalcify the bones, we treated whole mouse bodies with aminoalcohols 5, 15 and EDTA 25 before the whole-body immunolabeling step. Combination of these diverse improvements allowed us to achieve whole-body immunolabeling in adult mice with a high degree of transparency ( Fig. 2a and Supplementary Fig. 10 ) and to obtain quantitative information on single cells in deep brain regions through the intact skull 3, [15] [16] [17] [18] 23 (Supplementary Figs. 11 and 12) . Here, we used anti-XFP nanobodies conjugated with bright Atto dyes (called nanoboosters) to boost the fluorescent protein signal in transparent mice. Moreover, we used anti-vimentin nanobodies to label activated glia cells in the brain upon trauma, demonstrating that our approach also works with nanobodies targeting endogenously expressed proteins ( Supplementary Fig. 13 ).
In addition to the specific boosted signal, we also visualized and segmented other major tissues in the transparent body: muscles by their autofluorescence within the blue-green spectrum, and bones and internal organs by propidium iodide (PI) labeling (Fig. 2b,c and Supplementary Fig. 14a-d ). Usage of organic solvents, which induce isotropic tissue shrinkage 17 , allowed us to perform head-to-toe panoptic imaging of entire mice by light-sheet microscopy.
Being able to image subcellular details of neurons through intact bones and highly autofluorescent muscles in the whole mouse body using vDISCO panoptic imaging, we constructed the first wholebody neuronal projection map of a Thy1-GFP-M transgenic mouse ( Fig. 2d ,e, Supplementary Fig. 14 and Supplementary Video 2). We noticed that in the peripheral nervous system, mainly axons innervating muscles were labeled in this mouse line, which enabled us to investigate the neuromuscular junctions in greater detail. We also observed fluorescent labeling of the internal organs, such as kidneys of Thy1-YFP-H mice 21 ( Supplementary Fig. 15 ). Owing to the great increase in signal-to-background ratio by vDISCO, we could readily visualize axonal projections from the spinal cord through intact vertebrae to their terminals into the muscles, even in very remote locations such as toes ( Fig. 2f -i and Supplementary Videos 3 and 4). Panoptic imaging of individual neuronal projections through intact bones can now provide more details on neuroanatomy. For example, how axons coming from consecutive roots enter the spinal cord-that is, in an overlapping or non-overlapping manner-has been unclear 26 . Using our technology, we observed that in mice, the 
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NATure NeurOSCIeNCe axonal bundles coming from different roots enter the spinal cord at non-overlapping territories ( Supplementary Fig. 16 ). Thus, the vDISCO approach provides a holistic view of the intact mouse, which should lead to novel discoveries on how interconnected organ systems function in health and what happens during their perturbation in disease.
Clearing of the whole body without removal of the skin. The skin is the largest organ, forming ~15-20% of the body. Among many other components, it consists of nerve endings, glands, immune cells, blood and lymphatic vessels, signifying its diverse biological roles in addition to being a physical barrier against the external environment 27 . However, clearing and imaging whole mice with skin has not been reported. Towards this goal, we adopted the vDISCO protocol to clear and image mice with skin. We observed that vDISCO could efficiently clear whole nude mice without removal of the skin (Fig. 3a,b ). In addition, we cleared C57BL/6J (BL6) background mice after shaving the fur. In CX3CR1 GFP/+ mice, we could readily image 
NATure NeurOSCIeNCe immune cells through the intact skin owing to the increase of fluorescent signal by vDISCO ( Fig. 3c-h and Supplementary Video 5). In Thy1-GFP-M mice, we observed the axonal innervations in the skin in addition to Thy1 GFP + immune cells 28 located under the skin ( Fig. 3i-k) . These results demonstrate that vDISCO allows detailed imaging of intact mice with skin, which may be of great value for studying skin-related pathologies.
Degeneration of peripheral nerve terminals after brain injury. Traumatic brain injury (TBI) is a major cause of death and disability, and currently there is no disease-modifying treatment available to combat especially chronic sequelae. In addition to its acute consequences, TBI often leads to chronic focal and global neurological impairments, such as dementia, epilepsy, progressive motor decline, peripheral neuropathy and dystonia 29, 30 . These impairments could be due to degeneration of the corresponding brain regions and/or the dysfunction of nerves outside of the brain. However, so far, the impact of TBI on long-range neuronal projections outside of the brain has not been assessed. For example, while TBI-induced sensory-motor dysfunction has been observed in both animal models and human pathologies [31] [32] [33] [34] , the underlying mechanisms remain unknown, hampering the development of effective therapeutic approaches. Here, imaging the whole CNS, we found extensive neurodegeneration of the descending motor axons in the brainstem and spinal cord upon TBI over the right somatosensory and motor cortices ( Supplementary Fig. 17 ). However, how TBI alters neuronal projections in the peripheral nervous system remains elusive. We used panoptic imaging to examine neuronal changes throughout the body more than a month after the brain injury (chronic stage) in comparison with control animals. As mainly axons innervating muscles are labelled in Thy1-GFP-M mice, we primarily focused on these nerve terminals. Our quantifications conducted in intact cleared mouse bodies demonstrated that the complexity of nerve terminals at the neuromuscular junctions was reduced after TBI, especially in the upper torso, compared with unlesioned control mice ( Fig. 4a-d ). We observed that nerve endings were reduced in complexity at the contralateral body regions, with fewer axonal ramifications left, implying partial degeneration of these axon terminals (Fig. 4e,f ). Interestingly, we also observed changes at the ipsilateral axons, albeit to a smaller degree with respect to the contralateral body region (Fig. 4e ). Overall, these data demonstrate that light-sheet microscopy imaging of entire transparent mouse bodies by vDISCO holds great promise for discovering hitherto unknown biological and pathophysiological processes.
Visualizing new routes for immune cell trafficking in the brain and spinal cord. The lymphatic system, which connects various lymphatic organs in the body, is crucial for immune responses. Until recently, the brain was considered to be devoid of any lymphatic vessels. In recent years, brain lymphatic vessels were re-discovered and are considered to play critical roles in brain pathologies [35] [36] [37] [38] . As these lymphatic vessels are located between the brain and the skull 39 , their connections are largely destroyed when the brain is harvested for standard histology.
We utilized panoptic imaging to overcome this hurdle and imaged details of meningeal vessels in intact transparent mice. We used Prox1-EGFP reporter mice, in which lymphatic endothelial cells express EGFP 40 . We readily observed previously described brain lymphatic structures, particularly along the sagittal sinus, pterygopalatine artery and transverse sinus ( Fig. 5a-e and Supplementary Fig. 18 ) in addition to many other body regions ( Supplementary Fig. 19 and Supplementary Video 6). Next, we imaged multiple subtypes of immune cells within and outside the meningeal vessels using the CX3CR1 GFP/+ × CCR2 RFP/+ mice by multiplexing with two different nanoboosters (anti-GFP conjugated to Atto-647N and anti-RFP conjugated to Atto-594N). The CX3CR1 GFP + microglia cells in the brain parenchyma ( Fig. 5f ,g) and CCR2 RFP + peripheral immune cells in the meningeal vessels were clearly identifiable (Fig. 5g,h and Supplementary Video 7). As expected, we also observed CX3CR1 GFP + immune cells in meningeal vessels, which likely represent meningeal monocytes and macrophages ( Fig. 5h ). It remains unclear how the immune cells within meningeal vessels contribute to the pathology of acute brain injuries, as they may be in an advantageous position to invade the brain. To start addressing this query, we used the middle cerebral artery occlusion (MCAO) model of stroke, which was performed in LysM-EGFP mice, a transgenic mouse line expressing EGFP in myeloid cells (mainly in neutrophils and monocytes) but not in microglial cells 41 . The mice with MCAO showed an invasion of LysM GFP + cells into the brain parenchyma, especially in the peri-infarct region, compared with sham-operated controls (Fig. 5i,j) . Numbers of LysM GFP + cells also increased in the meningeal structures after MCAO ( Fig. 5i ), suggesting that the meninges might play a role as entry and/or exit routes of the brain in addition to the disrupted blood-brain barrier and the choroid plexus 42 . Thus, vDISCO panoptic imaging of transparent mice is a powerful tool to study the anatomy and cellular repertoire of meningeal vessels in health and disease.
Next, we aimed at investigating vascular connections between the skull and the meninges in greater detail. Towards this goal, we injected a cerebrospinal fluid (CSF) tracer (fluorophore-conjugated ovalbumin) into the cisterna magna in VEGFR3-YFP mice, another commonly used reporter line for meningeal vessels. We observed that the CSF tracer was quickly transported into the VEGFR3 + meningeal vessels ( Fig. 6a-d ). Interestingly, we also observed that the tracer-labeled vessels extended into the skull (Fig. 6b,c) . We further investigated the details of these new connections using lectin, another vessel tracer binding to endothelial cells. We found that these vascular connections are mostly located between the skull marrow and the outer surface of the meninges (both at the brain and sagittal sinus interfaces; Fig. 6e ,f, Supplementary Fig. 20 and Supplementary Videos 8 and 9). We measured that they have an average size of 46.9 ± 5.8 µ m in length and 19.2 ± 2.5 µ m in width at the brain interface and of 83.7 ± 0.3 µ m in length and 28.5 ± 1.8 µ m in width at the sagittal sinus interface (mean ± s.e.m., n = 3 mice; Supplementary Fig. 20) ; therefore, we named them as short skullmeninges connections (SMCs). They also occasionally contain cells (Fig. 6e,f and Supplementary Fig. 20 ). To address whether the SMCs might play a role in neuropathological conditions, we studied the distribution of LysM GFP + immune cells in these connections after MCAO. The mice with MCAO showed significantly more LysM GFP + cells in the SMCs compared with sham-operated controls ( Fig. 6g-i and Supplementary Video 10), suggesting that they might represent an entry route for myeloid cells from the skull marrow to the meningeal compartments after brain injury. Thus, vDISCO imaging revealed connections between skull and meninges, which might be important for immune cell trafficking, especially during brain pathologies.
Finally, we explored the immune cell trafficking after spinal cord injury using vDISCO panoptic imaging. To this end, we induced a spinal cord injury in CD68-EGFP transgenic mice expressing EGFP in monocytes and macrophages 43 . Upon spinal cord injury, we observed an influx of CD68 GFP + cells at the lesion site as well as a rather widespread increase in CD68 GFP + cells around the spinal cord ( Supplementary Fig. 21 and Supplementary Video 11). Indeed, only 3.5% of these phagocytes were seen in the injured spinal cord, while ~96.5% of the CD68 GFP + cells were located in the surrounding tissues of the spinal cord including adjacent muscles, spinal cord roots and meningeal vessels, similar to sham mice ( Supplementary  Fig. 22 ). Thus, vDISCO is a powerful tool to image and quantify the trafficking of immune cells to and within the injured CNS.
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Discussion
Panoptic imaging of transparent adult mouse bodies from head to toe holds the promise of providing an unbiased and highly resolved view of entire organ systems in health and disease. Here, we developed a new whole-body nanobody labeling method in conjunction with whole-body tissue clearing, enabling a reliable visualization and quantification of subcellular details throughout centimeters-thick tissues of intact mouse bodies. This new panoptic imaging technology is straightforward in application and is suitable for systemic analysis of a vast range of biomedical inquires, as demonstrated here in visualization of the neuronal projections in whole mouse bodies, the description of vascular pathways between the skull and meninges, and the visualization of remote neuronal and immune consequences of acute CNS injury models. While we developed vDISCO for panoptic imaging of the whole mouse body, it is readily applicable for individual organs, using a simplified protocol to drastically increase and stabilize the signal contrast, as we show for mouse brains imaged more than a year after boosting and clearing ( Supplementary Video 12 and Supplementary Table 1 ).
The panoptic imaging of nervous and immune systems in intact mouse bodies was achieved owing to the massive enhancement of the signal intensity by one to two orders of magnitude via wholebody immunolabeling employing nanobodies conjugated to bright dyes in the far-red spectrum. Therefore, the strong autofluorescence of tissues in shorter-wavelength spectra, in which traditional fluorescent proteins such as GFP are excited and imaged, is avoided. Here, we primarily used Atto dyes at 647 nm, and additional Atto 594 nm for multiplexing two different cell types. In the future, usage of nanobodies conjugated to dyes that emit in the near-infrared range 44 can further facilitate multiplexed detection of more than two targets. While the number of commercially available nanobodies is still limited, the nanoboosters used in this study can stain a broad selection of 21 different fluorescent proteins including EGFP, YFP, Venus, mCherry, and mRFP. Our method can also be used with nanobodies against endogenous proteins, as we demonstrated using anti-vimentin nanobodies labeling activated glia cells in the brain upon trauma 45, 46 . Currently, nanobodies are developed mainly for in vivo applications due to their small size (for example, for crossing the blood-brain barrier) 47 ; therefore, they are mostly selected for for the contralateral side, n = 6 animals per group; for the ipsilateral side, n = 6 mice for the TBI group and 5 mice for the unlesioned group, respectively; statistical significance (**P = 0.003, *P = 0.03) was assessed by two-tailed t test). f, Representative illustration showing the peripheral nerve ending morphology in TBI versus control mice.
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Here, we used transgenic mice endogenously expressing fluorescent proteins; however, the labeling can also be achieved by rabies virus retrograde tracing, systemic adeno-associated virus injections 48 or transplantation of genetically engineered cells (such as stem cells or adoptive transfer of immune cells). Another key advantage of vDISCO panoptic imaging is that upon staining with Atto dyes through nanoboosting, the signal becomes permanent, permitting long-term imaging sessions and future re-analysis of the same sample if needed. This also enables high-resolution imaging 
NATure NeurOSCIeNCe of desired body parts by confocal or two-photon microscopy. Indeed, the samples from this study are available to the scientific community upon request for further studies. We believe making vDISCO-treated samples accessible to other labs for further studies can save time and resources, reduce the number of mice used in experimental research and create more powerful datasets by allowing direct correlation of various inquiries by multiple studies from the same animals. A current limitation is the absence of light-sheet microscope systems that could image the entire body of a mouse in one session without any displacement and turning of the sample. Construction of such new light-sheet microscopes should further decrease the time needed for data acquisition and simplify data processing for 3D reconstruction. In fact, as shown here, optics and light sources of current commercial light-sheet microscopes are sufficient to image intact mouse bodies at subcellular resolution, although the whole body has to be manually moved in the imaging chamber to achieve the scanning of different body regions. In addition, development of machine learning-based (artificial intelligence) algorithms to automatically identify and quantify cellular changes on the wholeorganism scale will be important to further scale up this technology in the future.
Using panoptic imaging, we constructed a neuronal projection map for the Thy1-GFP-M transgenic line, showing subcellular details of long-range neuronal connections from the CNS to the distal extremities. Here, we visualized neuronal details in Thy1-GFP-M mice, in which only a subset of CNS neurons and peripheral nervous system neurons innervating skeletal muscles are labeled. In the future, panoptic imaging of other transgenic lines labeling a greater and more diverse subset of neurons will allow the exploration of other biological systems such as the autonomic innervation of internal organs.
In recent years, researchers have been providing more evidence on post-TBI changes that seem to form the basis of chronic complications, such as epilepsy, neuropsychiatric disorders, dementia and progressive motor decline 29 . However, the effects of a localized brain lesion on the rest of the body have been poorly understood, mainly due to the technical challenges in studying long-range neuronal projections. Because vDISCO fluorescent signal boosting allows both imaging and quantifications of light-sheet microscopy images of transparent mouse bodies, we identified TBI-induced changes at the peripheral axonal projections innervating the skeletal musculature of the torso. These data are in line with recent work by others and us demonstrating the functional deficits in fine motor movements in mice and the presence of sensory-motor dysfunctions in TBI patients 29, 30, 33 . Our data provide a possible cellular mechanism for these functional impairments, suggesting that they could arise due to degeneration of long-range axons throughout the spinal cord and peripheral nervous system. This discovery opens alternate avenues for the identification of therapeutic targets. For instance, recent literature showed that microtubule stabilization is a powerful way to block degeneration of axons in spinal cord injury 49 . In this regard, it would be important to assess whether microtubule stabilization would also counteract axon degeneration outside of the brain and circumvent the development of chronic sensorymotor dysfunctions. Here, we also demonstrated that meningeal vessels extending between the cranium and CNS tissue and their cellular content can readily be imaged by vDISCO panoptic imaging in naïve animals and acute CNS injury models. Importantly, we observed short vascular connections between the skull and meninges both at the brain interface (recently seen also by others 50 ) and at the sagittal sinus, which were filled with immune cells following ischemic stroke injury. Most of the SMCs seem to be open both at the skull marrow and meningeal ends without being connected to the vascular system of the brain/head (Supplementary Video 9) . In the future, it will be important to identify to which meningeal compartment or compartments (subdura, subarachnoid or subpial) the SMCs are connected. In addition, due to the present lack of appropriate reporter mice, it was not possible to distinguish the type of SMCs (blood or lymphatic vessels) with increased LysM + cells after stroke. In the future, vDISCO imaging of immune cells in a lymphatic vessel reporter mouse line with different fluorescent proteins (for example, LysM-EGFP + Prox1-RFP double reporter) could reveal more details of this new route for immune cell infiltration. As neuroinflammation is a major determinant of neuronal function and survival following CNS injuries of various etiologies, our technology should accelerate investigation of these novel immune cell infiltration routes in various CNS pathologies.
In conclusion, vDISCO enhancement and stabilization of fluorescent proteins combined with signal acquisition in far-red spectra should facilitate discovery of previously inaccessible biological information. For example, imaging and quantification of neuronal projections, vascular organizations and immune cell populations in the entire mouse body should contribute to a more comprehensive understanding of the initiation, progression and extent of neurological conditions.
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NATure NeurOSCIeNCe Methods Animals. We used the following mixed-gender animals in the study: CX3CR1 GFP/+ (B6.129P-Cx3cr1tm1Litt/J; Jackson Laboratory strain code 005582) 51 Within each strain, animals were randomly selected. Animals that resulted negative for the expression of fluorescent proteins by genotyping were excluded from the study. No statistical methods were used to pre-determine sample sizes, but our sample sizes are similar to those reported in previous publications 17 .
TBI. TBI was performed using a controlled cortical impact device (Leica Benchmark Stereotaxic Impactor, 39463923). At 30 min before surgery, we administered carprofen (4 mg per kg body weight) and buprenorphin (0.05 mg per kg) to the animals via subcutaneous injection. Then, anesthesia was induced in animals with 4% isoflurane in a N 2 O/O 2 (70%/30%) mixture and afterwards maintained with 1.5% isoflurane in the same mixture for the whole surgery. As soon as the animals did not show any pedal reflex, they were placed in the associated stereotaxic apparatus, and their body temperature was kept at 37 °C using a heating pad for the whole surgery procedure. Next, the scalp of the animals was shaved, aseptically prepared by wiping with Octenisept (Schülke, 22580-A) as disinfectant and the skin of the scalp was incised longitudinally between the occiput and forehead. We identified the target area of the injury, which was the right somatosensory cortex extending to the motor cortex, using the stereotaxic frame (bregma coordinates: 2 mm posterior, 5 mm right lateral). The injury was then triggered via controlled cortical impact machine using the following parameters: impact speed, 6.9 m s −1 ; impact duration, 400 ms; impact depth, 2 mm. With these parameters, the resulting injury was severe, with cracks in the skull, bleeding and exposed brain tissue. After the impact, the skin was sutured with metallic wound closure clips (VWR, 203-1000), and the animals were kept at 31 °C in a recovery chamber (Mediheat, 34-0516) for at least 30 min until they recovered from the anesthesia. In the following days, animals were subcutaneously injected with carprofen (4 mg per kg) once per day for 4 d and sacrificed at > 1 month postinjury by transcardial perfusion according to the 'Perfusion and tissue preparation' section below.
MCAO model. Experimental stroke was induced using the intraluminal filament model of MCAO (fMCAO) for transient, focal brain ischemia. Mice were anesthetized with isoflurane delivered in a mixture of 30% O 2 and 70% N 2 O. A heat-blunted nylon suture (6/0) was inserted into the external carotid artery and advanced until it obstructed the middle cerebral artery together with the ligation of the common carotid artery for 30 min. Regional cerebral blood flow (bregma coordinates: 2 mm posterior, 5 mm lateral) was continuously recorded by transcranial laser Doppler flowmetry from the induction of ischemia until 10 min after reperfusion. Following fMCAO, mice were placed in temperature-controlled recovery cages for 2 h to prevent post-surgery hypothermia. For the survival period (3 d), the mice were kept in their home cage with facilitated access to water and food. Sham-operated mice received the same surgical procedure without insertion of the filament. Body temperature was maintained throughout surgery using a feedback-controlled heating pad and kept constant (37.0 ± 0.5 °C). Exclusion criteria were as follows: insufficient MCAO (a reduction in blood flow to 15% of the baseline value) and blood flow recovery > 80% within 10 min of reperfusion. Mice were sacrificed at 3 d post-injury by transcardial perfusion according to the 'Perfusion and tissue preparation' section below.
Cisterna magna injection for meningeal vessel labeling.
For the cisterna magna injections, mice (VEGFR3-YFP; 6 months old) were anesthetized with a mixture of ketamine and xylazine (100 mg per kg and 10 mg per kg, respectively) via intraperitoneal injection. After toe pinch reflexes ceased, mice were fixed in a stereotaxic frame by the zygomatic arch, with the head slightly tilted to form an angle of 120° in relation to the body. The head and neck regions were shaved to expose the neck muscles, which were bluntly dissected to expose the cisterna magna. Cannulas composed of a dental needle (SOPIRA Carpule 30 G 0.3 × 12 mm; Kulzer, AA001) and polyethylene tubing (0.024 in OD (outside diameter) × 0.011 in ID (interior diameter); Scandidact, PE10-CL-500) were used to perform the cisterna magna injections. A cannula filled with CSF tracer (2% ovalbumin 45 kDa conjugated to Alexa Fluor 647 (Thermo Fisher Scientific, O34784), diluted in artificial CSF (126 mM NaCl, 2.5 mM KCl, 1.25 mM NaH 2 PO 4 , 2 mM Mg 2 SO 4 , 2 mM CaCl 2 , 10 mM glucose, 26 mM NaHCO 3 ; pH 7.4 when gassed with 95% O 2 and 5% CO 2 )) was inserted into the cisterna magna. With the aid of an injection pump (LEGATO 130 Syringe pump; KD Scientific, 788130), 10 µ l of CSF tracer was injected into the cisterna magna at a rate of 1 µ l min −1 . At the end of the injection, CSF tracer was allowed to circulate in the subarachnoid and paravascular spaces for 1 h. Mice were then transcardially perfused according to the 'Perfusion and tissue preparation' section below.
Spinal cord injury model. Mice were deeply anesthetized by intraperitoneal injection of a combination of midazolam (5 mg per kg), medetomidine (0.5 mg per kg) and fentanyl (0.05 mg per kg). The mid-thoracic spinal cord of anesthetized CD68-EGFP mice was surgically exposed by a dorsal laminectomy as previously described 52 . A hemisection of the spinal cord was performed using fine-tip surgical scissors (Fine Science Tools 15000-08 spring scissor, 2.5 mm cutting edge). For sham surgery, the dorsal laminae of mid-thoracic vertebrae were surgically exposed in anesthetized CD68-EGFP mice. After spinal cord injury or sham surgery, muscle tissue and skin were sutured with a surgical thread (Ethilon suture 6-0, 667 H) and animals were allowed to recover on a heating pad. After 48 h, mice were transcardially perfused according to the 'Perfusion and tissue preparation' section below.
Perfusion and tissue preparation. Mice were deeply anesthetized using a combination of midazolam, medetomidine and fentanyl (MMF; 1 ml per 100 g body mass for mice; intraperitoneal). As soon as the animals did not show any pedal reflex, they were intracardially perfused with heparinized 0.1 M PBS (10 U ml −1 of heparin, Ratiopharm; ~110 mmHg pressure using a Leica Perfusion One system) for 5-10 min at room temperature until the blood was washed out, followed by 4% paraformaldehyde (PFA) in 0.1 M PBS (pH 7.4; Morphisto, 11762.01000) for 10-20 min. Next, optionally, skin and eyes as well as premaxilla and maxilla bones were carefully removed, the palate of the animal was opened (without damaging the tissue beneath), and the feces were gently washed out from the intestine with 0.1 M PBS through small cuts using a syringe. For the animals cleared with skin, the skin was not removed from the bodies, and in case of BL6 background animals, the fur was shaved off using a razor blade (Personna, 604305-001001). Then, the bodies were post-fixed in 4% PFA for 1 d at 4 °C and later washed with 0.1 M PBS for 10 min 3 times at room temperature. Either the whole-body nanoboosting procedure was started immediately or whole mouse bodies were stored in PBS at 4 °C for up to 4 weeks or in PBS containing 0.05% sodium azide (Sigma-Aldrich, 71290) for up to 6 months.
For the collection of dissected tissues such as brains, mice were perfused with PBS and PFA as described above. Subsequently, the organs of interest were dissected out and post-fixed in 4% PFA overnight at 4 °C, washed with 0.1 M PBS for 10 min 3 times at room temperature and kept in PBS plus 0.05% sodium azide for up to 3 weeks.
Clearing of unboosted samples. For the quantification of fluorescence signal after clearing, without boosting, we followed the uDISCO passive clearing protocol as described by Pan et al. 17 . In brief, dissected brains were placed in 5 ml tubes (Eppendorf, 0030 119.401) and covered with 4.5 ml of clearing solution. All incubation steps were performed in a fume hood with gentle shaking or rotation, with the samples covered with aluminum foil to keep them in dark. To clear the samples, we incubated them in a gradient of tert-butanol (Sigma-Aldrich, 360538): 30 vol%, 50 vol%, 70 vol%, 80 vol%, 90 vol%, 96 vol% (in distilled water), and 100 vol% twice at 35 °C for 12 h each step followed by immersion in dichloromethane (Sigma-Aldrich, 270997) for 45-60 min at room temperature and finally incubation with the refractive index matching solution BABB-D15, containing 15 parts BABB (benzyl alcohol + benzyl benzoate 1:2; Sigma-Aldrich, 24122 and W213802), 1 part diphenyl ether (Alfa Aesar, A15791) and 0.4 vol% vitamin E (dl-α -tocopherol; Alfa Aesar, A17039), for at least 6 h at room temperature until transparency was achieved.
Nanobodies, antibodies and fluorescent dyes used in this study. The nanobodies, antibodies and fluorescent dyes used in this study are as follows: Atto594conjugated anti-RFP nanobooster (Chromotek, rba594-100), Atto647N-conjugated anti-GFP nanobooster (Chromotek, gba647n-100), Atto488-conjugated anti-GFP nanobooster (Chromotek, gba488-100), Atto488-conjugated anti-vimentin nanobooster (Vimentin-Label_Atto488; Chromotek, vba488-100), Alexa647conjugated anti-GFP antibody (Invitrogen, A31852), and PI (Sigma-Aldrich, P4864). For the nanobody and antibody validation information, see the Life Sciences Reporting Summary.
Validation of nanoboosters for vDISCO. Post-fixed brains from fluorescent proteinexpressing mice (for example, Thy1-GFP-M) were cut into 400 µ m slices using a vibratome (Leica, VT1200S). The slices were imaged before staining with a Zeiss AxioZoom EMS3/SyCoP3 fluorescence stereomicroscope to make sure that the samples have fluorescent protein expression. All the following steps were done with gentle shaking. The slices were first incubated for 3 h in a 24 multiwell (Falcon,
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NATure NeurOSCIeNCe 353504) at 37 °C with 1 ml of permeabilization solution containing 1.5% goat serum (Gibco, 16210072), 0.5% Triton X-100 (AppliChem, A4975,1000), 0.5 mM of methyl-β -cyclodextrin (Sigma-Aldrich, 332615), 0.2% trans-1-acetyl-4-hydroxyl-proline (Sigma-Aldrich, 441562) and 0.05% sodium azide (Sigma-Aldrich, 71290) in 0.1 M PBS. Subsequently, they were incubated overnight at 37 °C with the same permeabilization solution, and the nanobooster of interest was added with dilution 1:500 considering final volume = 500 µ l. The multiwell was covered with aluminium foil to keep the slices in dark and was sealed well with parafilm (Bemis, PM-992) to prevent the solution from drying out. One slice was kept as negative control where there was no adding of nanobooster. After the incubation, slices were washed with the washing solution (1.5% goat serum, 0.5% Triton X-100, 0.05% sodium azide in 0.1 M PBS) at room temperature for 15 min 4 times and then washed with 0.1 M PBS at room temperature for 10 min 3 times. Then the slices were imaged again after staining with the AxioZoom microscope to check whether the staining worked. In the end, slices were moved to 5 ml Eppendorf tubes wrapped with aluminium foil to keep them in dark and cleared with 3DISCO protocol: first they were incubated at room temperature in the following gradient of tetrahydrofuran (THF; Sigma-Aldrich, 186562) in distilled water (45 min for each step): 50 vol% THF, 70 vol% THF, 80 vol% THF, 100 vol% THF and 1 h 100 vol% THF; after dehydration, samples were incubated for 15 min in dichloromethane, and finally in BABB until transparency. Finally, the slices were imaged again with the AxioZoom microscope to make sure that the staining worked even after clearing. For more details of the AxioZoom imaging setup, see the 'Fluorescence stereomicroscopy imaging' section below.
vDISCO whole-body immunostaining, PI labeling and clearing. In order to remove remaining blood and heme after PFA perfusion, and to decalcify the bones, the animals were subjected to perfusion with decolorization solution and decalcification solution before immunostaining. The decolorization solution was made with 25-30 vol% dilution of CUBIC reagent 1 5 The solutions for the immunolabeling pipeline were pumped inside the body of the animal by transcardial-circulatory perfusion, exploiting the same entry point hole into the heart created during the PBS and PFA perfusion step (see above) and following the procedure described by Pan et al. 17 . In brief, the mouse body was placed in a 300 ml glass chamber (Omnilab, 5163279) filled with 250-300 ml of appropriate solution, which covered the body completely. Next, the transcardialcirculatory system was established involving a peristaltic pump (ISMATEC, REGLO Digital MS-4/8 ISM 834; reference tubing, SC0266), keeping the pressure at 160-230 mmHg (45-60 r.p.m.). One channel from the pump, made by a single reference tube, was set for circulation of the solution through the heart into the vasculature: one ending of the tube was connected to the tip of a syringe (cut from a 1 ml syringe; Braun, 9166017V) which held the perfusion needle (Leica, 39471024), and the other ending was immersed in the solution chamber where the animal was placed. The perfusion needle pumped the appropriate solution into the mouse body, and the other ending collected the solution exiting the mouse body to recirculate the solution, pumping it back into the animal. To fix the needle tip in place and to ensure extensive perfusion, we put a drop of superglue (Pattex, PSK1C) at the level of the hole where the needle was inserted inside the heart. Using the setting explained above, after post-fixation and PBS washing, the mice were first perfused with 0.1 M PBS overnight at room temperature; then, the animals were perfused with 250 ml of decolorization solution for 2 d at room temperature, exchanging with fresh decolorization solution every 6-12 h until the solution turned from yellowish to clear and the spleen became lighter in color (indicating that the blood heme was extracted). Then, they were perfused with 0.1 M PBS, washing for 3 h 3 times, followed by perfusion with 250 ml of decalcification solution for 2 d at room temperature and again perfusion/washing with 0.1 M PBS for 3 h 3 times. After this, the animals were perfused with 250 ml of permeabilization solution containing 1.5% goat serum, 0.5% Triton X-100, 0.5 mM of methyl-β -cyclodextrin, 0.2% trans-1-acetyl-4-hydroxy-l-proline and 0.05% sodium azide in 0.1 M PBS for half a day at room temperature. Subsequently, the perfusion proceeded further, through connection of a 0.20 µ m syringe filter (Sartorius, 16532) to the ending of the tube not holding the needle to efficiently prevent accumulation of dye aggregates into the sample. At the same time, from this step we used an infrared lamp (Beuer, IL21) directed to the chamber to heat up the solution to 26-28 °C. With this setting, the animals were perfused for 6 d with 250 ml of the same permeabilization solution containing 35 µ l of nanobooster, which is 20-35 µ g in 250 ml (0.08-0.14 µ g ml −1 ), 1:7,000 in dilution (stock concentration 0.5-1 mg ml −1 ; the amount of nanobody was adjusted depending on the expected presence of fluorescent protein in the mouse body) and 290 µ l of PI (stock concentration 1 mg ml −1 ). Next, we removed the animals from the chamber, and with fine scissors we removed a tiny piece from the back of the skull (above the cerebellum) at the level of the occipital bone; we then placed the bodies in a 50 ml tube (Falcon, 352070) filled with the same permeabilization solution containing an extra 5 µ l of nanobooster and incubated the tubes at 37 °C with gentle shaking for an additional 2-3 d of labeling. After that, the mice were placed back in the perfusion system, and labeling solution was washed out by perfusing with washing solution (1.5% goat serum, 0.5% Triton X-100, 0.05% of sodium azide in 0.1 M PBS) for 3 h 3 times at room temperature and 0.1 M PBS for 3 h 3 times at room temperature.
After the staining, the animals were cleared using a 3DISCO-based passive whole-body clearing protocol optimized for big samples. The mice were incubated at room temperature in dehydration and clearing solutions inside a 300 ml glass chamber, kept with gentle rotation on top of a shaking rocker (IKA, 2D digital) inside a fume hood. For dehydration, mice bodies were incubated in 200 ml of the following gradient of THF in distilled water (12 h for each step): 50 vol% THF, 70 vol% THF, 80 vol% THF, 100 vol% THF and again 100 vol% THF, followed by 3 h in dichloromethane and finally in BABB. During all incubation steps, the glass chamber was sealed with parafilm and covered with aluminum foil. See Supplementary Table 1 and http://www.discotechnologies.org/vDISCO/.
vDISCO whole-mount immunolabeling of individual organs. vDISCO was performed on dissected organs as well: dissected brains were stained using the immunolabeling protocol for dissected organs. First, the post-fixed brains were pretreated, incubating them for 2 d at 37 °C with gentle shaking in 4.5 ml of same solution used at the permeabilization step (see above). Subsequently, the brains were incubated in 4.5 ml of this same permeabilization solution plus the nanobooster of interest with the concentration adjusted to expression of the target (for example, Atto647N-conjugated anti-GFP nanobooster dilution 1:600, which is ~5-8 µ g of nanobooster in 4.5 ml (1.1-1.8 µ g ml −1 ; stock concentration, 0.5-1 mg ml −1 ) for Thy1-GFP-M brains) for 12-14 d at 37 °C with gentle shaking, then brains were washed for 2 h 3 times and once overnight with the washing solution (1.5% goat serum, 0.5% Triton X-100, 0.05% of sodium azide in 0.1 M PBS) at room temperature and in the end washed for 2 h 4 times with 0.1 M PBS at room temperature. The immunostained brains were cleared with 3DISCO clearing: first they were put in the Eppendorf 5 ml tubes, and then they were incubated at room temperature with gentle shaking in 4.5 ml of the following gradient of THF in distilled water (2 h for each step): 50 vol% THF, 70 vol% THF, 80 vol% THF, 100 vol% THF and overnight ;vol% THF; after dehydration, the samples were incubated for 1 h in dichloromethane and finally in BABB until transparency. During all the clearing steps, the tubes were wrapped with aluminum foil to keep them in dark. See Supplementary Table 1 .
For the comparison of deep-tissue staining efficiency in terms of penetration of the staining of nanobody versus conventional antibody ( Supplementary Fig. 2) , we followed the same protocol described above in this section for both nanobody and antibody experimental groups. The only exception was that for the antibody group, in the immunostaining step, we replaced the nanobooster with Alexa647conjugated anti-GFP antibody (Invitrogen, A31852) with the same concentration (see above).
Pumping pressure measurement. A KKmoon Digital Manometer Pressure
Gauge Manometer (HT-1891) was used to measure the pressure. To achieve one additional measuring channel to connect with the manometer, a two-head connector (B.Braun Discofix C Dreiwegehahn, 16494C) was inserted into the pumping channel, and the second head was further connected to the manometer with extended PVC tubing. The pumping channel was set in the standard way as described including a transcardiac perfusion needle. First, the switch on the twohead connector was set without connecting the measuring tubing, and pumping was started until all the air bubbles were excluded from the pumping channel. Subsequently, the switch was set to connect the measuring tubing while pumping was continued, and the pressure was measured when the manometer readouts stabilized. Three measurements were made at different time points including morning, afternoon and evening to exclude the variation of room temperature, and the data were quantified by averaging.
Comparison of high-pressure versus low-pressure perfusion with methylene blue. The diffusion of methylene blue (Sigma-Aldrich, M9140), perfused into the body of the animals, was used to compare the efficiency of high-pressure versus low-pressure perfusion ( Supplementary Fig. 8 ). For this purpose, we used 3 BL6 animals (4 months old) per experimental group: post-fixed whole bodies were perfused for 15 min with 0.05% methylene blue in 0.1 M PBS, at either 50 r.p.m. (~180 mmHg) for the high-pressure group or 25 r.p.m. (~70 mmHg) for the lowpressure group. The same pump setting explained in the section 'vDISCO wholebody immunostaining, PI labeling and clearing' was used, including the usage of superglue to fix the needle in place inside the hole in the heart. iDISCO+. Antibody validation: methanol compatibility test. Before performing the comparison of the efficiency between vDISCO nanobody staining and iDISCO+ antibody staining on whole brains, we verified the compatibility of the chosen antibody with the iDISCO+ protocol ( Supplementary Fig. 3a-d) . This was done performing the antibody validation step, which tested the compatibility of the antibody with the methanol pretreatment required by iDISCO+ . To do so, we followed the original iDISCO+ publication 23 and the latest protocol updates from https://idisco.info. Briefly, post-fixed brains from Thy1-GFP-M and CX3CR1 GFP/+
